These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior. Khine N, Mudawi D, Rivera-Ortega P, Leonard C, Chaudhuri N, Margaritopoulos GA. Sarcoidosis Vasc Diffuse Lung Dis; 2020 Sep; 37(2):231-233. PubMed ID: 33093788 [Abstract] [Full Text] [Related]
23. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study). Nasser M, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Hachulla E, Jouneau S, Le Lay K, Cottin V. Respir Res; 2021 May 24; 22(1):162. PubMed ID: 34030695 [Abstract] [Full Text] [Related]
24. Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease. Schmid U, Weber B, Magnusson MO, Freiwald M. Respir Med; 2021 May 24; 180():106369. PubMed ID: 33798871 [Abstract] [Full Text] [Related]
25. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis. Yu YF, Wu N, Chuang CC, Wang R, Pan X, Benjamin NN, Devercelli G, Coultas DB. J Manag Care Spec Pharm; 2016 Apr 24; 22(4):414-23. PubMed ID: 27023695 [Abstract] [Full Text] [Related]
26. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype. Takei R, Brown KK, Yamano Y, Kataoka K, Yokoyama T, Matsuda T, Kimura T, Suzuki A, Furukawa T, Fukuoka J, Johkoh T, Goto Y, Kondoh Y. Respirology; 2022 May 24; 27(5):333-340. PubMed ID: 35293077 [Abstract] [Full Text] [Related]
28. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival. Hyldgaard C. Dan Med J; 2015 Apr 24; 62(4):B5069. PubMed ID: 25872544 [Abstract] [Full Text] [Related]
29. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers. Faverio P, Piluso M, De Giacomi F, Della Zoppa M, Cassandro R, Harari S, Luppi F, Pesci A. Respiration; 2020 Apr 24; 99(10):838-845. PubMed ID: 33264777 [Abstract] [Full Text] [Related]
31. Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be. Goos T, De Sadeleer LJ, Yserbyt J, Verleden GM, Vermant M, Verleden SE, Wuyts WA. J Clin Med; 2021 Mar 23; 10(6):. PubMed ID: 33807034 [Abstract] [Full Text] [Related]